Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma.

Oymanns, Mathias; Daum-Marzian, Michael; Bellm, Aliyah; Elsayad, Khaled; Eich, Hans T; Assaf, Chalid

Oymanns, Mathias; Daum-Marzian, Michael; Bellm, Aliyah; Elsayad, Khaled; Eich, Hans T; Assaf, Chalid.

Afiliación

Oymanns M; Department of Dermatology and Venerology, Helios Klinikum Krefeld, Krefeld, Germany.
Daum-Marzian M; Department of Radiotherapy and Radiooncology, Helios Klinikum Krefeld, Krefeld, Germany.
Bellm A; Department of Pediatrics, HELIOS Klinikum Krefeld, Krefeld, Germany.
Elsayad K; Department of Radiation Therapy and Radio-Oncology, University Hospital Münster, Münster, Germany.
Eich HT; Department of Radiation Therapy and Radio-Oncology, University Hospital Münster, Münster, Germany.
Assaf C; Department of Dermatology and Venerology, Helios Klinikum Krefeld, Krefeld, Germany.

Br J Dermatol ; 188(1): 145-146, 2023 01 23.

Article en En | MEDLINE | ID: mdl-36689504

Asunto(s)

Inmunoconjugados; Linfoma Cutáneo de Células T; Neoplasias Cutáneas; Humanos; Brentuximab Vedotina; Electrones; Linfoma Cutáneo de Células T/patología; Neoplasias Cutáneas/patología; Antígeno Ki-1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Inmunoconjugados Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google